Psyence Biomedical Ltd Stock Probability of Future Stock Price Finishing Over 12.04
| PBM Stock | USD 3.46 0.05 1.42% |
Psyence |
Psyence Biomedical Target Price Odds to finish over 12.04
The tendency of Psyence Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 12.04 or more in 90 days |
| 3.46 | 90 days | 12.04 | about 31.55 |
Based on a normal probability distribution, the odds of Psyence Biomedical to move over $ 12.04 or more in 90 days from now is about 31.55 (This Psyence Biomedical Ltd probability density function shows the probability of Psyence Stock to fall within a particular range of prices over 90 days) . Probability of Psyence Biomedical price to stay between its current price of $ 3.46 and $ 12.04 at the end of the 90-day period is about 49.25 .
Considering the 90-day investment horizon Psyence Biomedical Ltd has a beta of -0.0593 indicating as returns on the benchmark increase, returns on holding Psyence Biomedical are expected to decrease at a much lower rate. During a bear market, however, Psyence Biomedical Ltd is likely to outperform the market. Additionally Psyence Biomedical Ltd has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Psyence Biomedical Price Density |
| Price |
Predictive Modules for Psyence Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psyence Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Psyence Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Psyence Biomedical is not an exception. The market had few large corrections towards the Psyence Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Psyence Biomedical Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Psyence Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.9 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 6.35 | |
Ir | Information ratio | -0.33 |
Psyence Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psyence Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psyence Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Psyence Biomedical generated a negative expected return over the last 90 days | |
| Psyence Biomedical has high historical volatility and very poor performance | |
| Psyence Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0. | |
| Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Psyence Biomedical has a frail financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis |
Psyence Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Psyence Stock often depends not only on the future outlook of the current and potential Psyence Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psyence Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.5 M | |
| Cash And Short Term Investments | 733.2 K |
Psyence Biomedical Technical Analysis
Psyence Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Psyence Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Psyence Biomedical Ltd. In general, you should focus on analyzing Psyence Stock price patterns and their correlations with different microeconomic environments and drivers.
Psyence Biomedical Predictive Forecast Models
Psyence Biomedical's time-series forecasting models is one of many Psyence Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Psyence Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Psyence Biomedical
Checking the ongoing alerts about Psyence Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Psyence Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Psyence Biomedical generated a negative expected return over the last 90 days | |
| Psyence Biomedical has high historical volatility and very poor performance | |
| Psyence Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0. | |
| Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Psyence Biomedical has a frail financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis |
Check out Psyence Biomedical Backtesting, Psyence Biomedical Valuation, Psyence Biomedical Correlation, Psyence Biomedical Hype Analysis, Psyence Biomedical Volatility, Psyence Biomedical History as well as Psyence Biomedical Performance. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.